Publications
Publications
Show Results For
- All HBS Web
(3,654)
- Faculty Publications (1,345)
- October 2024
- Case
Sacoor Brothers: From Co-Family CEOs to No Family CEOs?
By: Lauren Cohen, David Ager and Alpana Thapar
Sacoor Brothers, a luxury clothing retail company, was founded in 1989 in Lisbon, Portugal, by four brothers—Malik, Salim, Rahimo, and Moez. After establishing a strong presence in Portugal, the brothers were drawn to the rapidly growing retail markets in the Middle... View Details
Keywords: Growth; Geographic Mobility; Family Office; Professionalization; Institutional Development; Second-generation; Third-generation; Family Business; Private Equity; Investment; Governance; Transition; Business Model; Growth and Development Strategy; Management Succession; Market Entry and Exit; Family and Family Relationships; Expansion; Retail Industry; Fashion Industry; Middle East; United Arab Emirates; Saudi Arabia; Portugal; Jordan; Dubai
- 2024
- Chapter
What Future for the Renminbi in the Global Monetary System?
By: Edoardo Campanella and Meg Rithmire
What is a realistic and positive outcome for US-China relations in the realm of global finance over the next ten years? While some policymakers, especially in the US, have feared that China holds ambitions for the renminbi (RMB) to replace the dollar as a global... View Details
- October 2024 (Revised January 2025)
- Case
Citizens of the World: The International Legacy of Gloria von Thurn und Taxis
By: Lauren Cohen, Maximilian Form and Sophia Pan
When her husband passed away and inheritance taxes struck, Princess Gloria von Thurn und Taxis took decisive action to preserve her family’s fortune and legacy. The Thurn und Taxis family, one of Europe’s oldest aristocratic dynasties, had built their wealth through... View Details
- October 2024
- Article
Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates
By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated... View Details
- 2024
- Working Paper
Foreign Influence in U.S. Politics
By: Marco Grotteria, Max Miller and S. Lakshmi Naaraayanan
This paper investigates the informational role of lobbyists in the context of foreign lobbying in the United States. Using Department of Justice data on contacts between foreign governments and US legislators, we show that exogenous shocks to these connections... View Details
- September 2024 (Revised March 2025)
- Supplement
Wemade: (Re)Establishing Trust in Blockchain Games (B)
By: Jung Koo Kang, Charles C.Y. Wang, David Allen and Kwangmoon So
This supplement reviews Wemade's efforts to rebuild confidence in its business after its WEMIX coin was delisted from the major South Korean cryptocurrency exchanges on December 8, 2022. It outlines Wemade's strategy of transparency, which included partnerships with... View Details
- September 2024
- Case
Faena: Magic in Mid-Miami Beach
By: Robin Greenwood, Denise Han, Dave Habeeb and Ruth Page
The link to this multimedia case should be provided to students in advance as preparation for classroom case discussion.
This multimedia case follows real estate developer Alan Faena as he expanded his luxury development business from Argentina to the... View Details
This multimedia case follows real estate developer Alan Faena as he expanded his luxury development business from Argentina to the... View Details
Keywords: Development; Real Estate; Hotels; Luxury; Urban Development; Sustainable Cities; Design; Markets; Transformation; Cost vs Benefits; Economic Growth; Private Sector; Public Sector; Economic Slowdown and Stagnation; Cultural Entrepreneurship; Financial Strategy; Investment Return; Geographic Location; Urban Scope; Corporate Accountability; Collaborative Innovation and Invention; Business and Community Relations; Business and Government Relations; Opportunities; Culture; Value Creation; Real Estate Industry; Entertainment and Recreation Industry; Florida; Miami; Argentina; Buenos Aires
- September 20, 2024
- Article
It’s Time to Unbundle ESG
By: Aaron K. Chatterji and Michael W. Toffel
ESG is at an inflection point. It has come to represent a broad and inchoate aspiration for what business should be doing beyond maximizing shareholder value. With ESG advocates on the defensive, business leaders need a new roadmap to determine which factors to... View Details
Keywords: ESG; ESG (Environmental, Social, Governance) Performance; ESG Ratings; ESG Reporting; ESG Disclosure; Sustainability; Climate; Climate Finance; Climate Risk; Social Accounting; Investment; Governance; Safety; Climate Change; Environmental Sustainability; Corporate Social Responsibility and Impact; Financial Services Industry
- 2024
- Working Paper
Changing Perceptions and Post-Pandemic Monetary Policy
By: Michael D. Bauer, Carolin Pflueger and Adi Sunderam
We document that the Fed’s perceived monetary policy response to inflation shifted materially over the post-pandemic period. In forward-looking policy rules estimated from surveys of macroeconomic forecasters, the inflation coefficient rose significantly after liftoff... View Details
- September 2024
- Case
Comun: Partners in Peril
By: Jeffrey J. Bussgang and Alexis Lefort
In spring 2023, Abiel Gutierrez and Andres Santos, co-founders of Comun, faced a critical decision at their fintech startup serving Latino immigrants. Having launched their product the previous year, they experienced rapid growth but encountered rising fraud and... View Details
- September 2024
- Case
Cathay Cargo: Turnaround Short Haul, or Double Crew Long Haul?
By: Willy Shih and Billy Chan
Tom Owen, Director Cargo at Cathay Pacific Airways, had a problem. During the Covid-19 pandemic, the grounding of passenger flights meant the sudden loss of 50% of the airline's cargo carrying capacity. But the bigger challenge was that the Hong Kong government imposed... View Details
- 2024
- Working Paper
Does Private Equity Have Any Business Being in the Health Care Business?
By: Nori Gerardo Lietz and Zirui Song
Private Equity (“PE”) has come under increased scrutiny by the press, academics, and policymakers, as well as the public, for its investments in health care delivery. This scrutiny has been exacerbated by recent high profile hospital bankruptcies following PE... View Details
- September 2024
- Article
Activist Directors: Determinants and Consequences
By: Ian D. Gow, Sa-Pyung Sean Shin and Suraj Srinivasan
This paper examines determinants and consequences of hedge fund activism, focusing on activist directors, i.e., directors appointed in response to activist demands. Using a sample of 3,259 activism events from 2004 to 2016, we identify 1,623 activist directors.... View Details
- 2024
- Working Paper
Voting Rules, Turnout, and Economic Policies
By: Enrico Cantoni, Vincent Pons and Jérôme Schäfer
In recent years, voter ID laws and convenience voting have generated heated partisan debates. To shed light on these policy issues, we survey the recent evidence on the institutional determinants and effects of voter turnout and broaden the perspective beyond the most... View Details
- August 2024 (Revised February 2025)
- Case
Novo Nordisk Foundation
By: Debora L. Spar and Julia M. Comeau
In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details
Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Profit; Corporate Governance; Business or Company Management; Corporate Social Responsibility and Impact; Expansion; Philanthropy and Charitable Giving; Nonprofit Organizations; Pharmaceutical Industry; Denmark; Europe
- August 2024
- Case
The Political Money Machine and Senator Cruz
By: Robert F. White and Jimena Marquez
This caselet explores campaign finance rules in U.S. elections, as illustrated through a fundraising memo for Senator Ted Cruz. View Details
- August 2024
- Case
Circle: Reinventing the Future of Money
By: Shikhar Ghosh and Shweta Bagai
In early 2024, Circle Internet Financial's leadership team gathered to discuss the company's strategic path as it prepared for an IPO. Founded in 2013 by Jeremy Allaire, Circle had emerged as a pioneer in digital finance through its USD Coin (USDC), a regulated... View Details
- July 2024 (Revised January 2025)
- Case
Dynamic Pricing at Wendy's: Where's the Beef?
By: Elie Ofek, Alicia Dadlani and Martha Hostetter
In early 2024, Wendy’s new CEO announced on an earnings call that the company would install digital menus in its US locations so it could begin testing dynamic pricing—changing prices up or down in response to shifts in supply and demand – as well as allow engaging in... View Details
- June 2024 (Revised January 2025)
- Background Note
Politics Comes to ESG Investing
By: Shawn Cole and Jonah Zahnd
While the past decade has seen a dramatic increase in the incorporation of Environmental, Social and Governance (ESG) standards into investor practices, this momentum has shifted recently in the United States, as some politicians argued that ESG investing practices... View Details
- June 2024 (Revised December 2024)
- Case
Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital
By: Joshua D. Margolis and Ahmed Dahawy
Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Pharmaceutical Industry; Jordan